The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease - Wikidata - wikimedia - TriplyDB

The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease

The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease

http://www.wikidata.org/entity/Q36142817

about

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.Clinical correlates of depressive symptoms in familial Parkinson's disease.Genetics of psychosis in Alzheimer's disease: a review Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice.Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.Does the apolipoprotein E epsilon 4 genotype influence the expression of depression with cognitive impairment?PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.Neurobiology of delusions in Alzheimer's disease.Behavioral and psychological symptoms of dementia and their management.Behavioural genetics of Alzheimer's disease: a comprehensive review.Identifying Common Genetic Risk Factors of Diabetic Neuropathies.Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.The influence of chronic stress on anxiety-like behavior and cognitive function in different human GFAP-ApoE transgenic adult male mice.Upregulation of Mineralocorticoid Receptor in the Hypothalamus Associated with a High Anxiety-like Level in Apolipoprotein E4 Transgenic Mice.Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.

P2860

Q21261380-752120C6-6F01-476B-BF25-6E25C7F77F28 Q33861294-083C70C9-0BEC-449B-A05B-A261F68515F0 Q34098861-52CD5CD2-1B7F-4CD5-B100-3BFA823F2677 Q34110834-857CDD0C-9AC9-4B32-82EF-C665CA2D89B9 Q34953672-4288E701-CE1A-403E-949F-3DA5D611A0D3 Q35755486-AB43AB06-CB60-4508-9E4B-6A7F0B4B4C5F Q35918948-89B42CE5-6DD8-4F1A-876B-17E1F5093318 Q37772498-85855581-3D8A-416B-BFCD-C70D87B16066 Q37853072-DC002326-577F-4F4C-AF32-A73BAD0BEA36 Q37854476-0F71C8D0-1604-4217-80A6-B531508407A2 Q37980139-534B9E00-CC98-4BF1-AEBE-1CE4B74D2AAD Q38527798-3F53D4C4-2A99-4E19-9F9F-7D6D8306C137 Q38802908-96B027D1-E5F9-4B4D-909D-A0D729505C54 Q38951554-6517BB0E-D31B-4F84-BAAE-5E9EABD81E45 Q47705256-973F3B54-522E-4373-A4F7-39D307AC4F1E Q48247745-B3F9255F-3C5B-4243-AFB6-8F0599BF5577 Q48280303-8265024C-30D7-4FDC-B743-20EE88F076E9 Q53322019-C67E6E17-936C-4F27-A8AB-008E510C978F

P2860

The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease

http://www.wikidata.org/entity/Q36142817

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

The effect of the apolipoprote ...... n probable Alzheimer's disease

@ast

The effect of the apolipoprote ...... n probable Alzheimer's disease

@en

type

label

The effect of the apolipoprote ...... n probable Alzheimer's disease

@ast

The effect of the apolipoprote ...... n probable Alzheimer's disease

@en

prefLabel

The effect of the apolipoprote ...... n probable Alzheimer's disease

@ast

The effect of the apolipoprote ...... n probable Alzheimer's disease

@en

P1433

Q36142817-5959CCD1-9C4D-4326-A47A-4E0A57318F1D

P1476

Q36142817-89584FE7-0672-41FB-9AD5-C91BB91E9F07

P2093

Q36142817-232A4284-EC7A-494D-9CAB-221C4C25EF05

Q36142817-399078B2-1A9D-47DC-9E5F-D273342EA815

Q36142817-506E348F-F3C4-4C8B-980F-EE54E0232DF1

Q36142817-64282E00-1C31-4435-9046-23B5375BDEE9

Q36142817-6A5B3159-FB0B-4C1A-ABEF-3798F78FF230

Q36142817-6ABBFBDD-E7B1-4472-A8FF-B0B365B94A84

Q36142817-775D1FE5-CDFB-4EA3-9A9E-1058BF4B36ED

Q36142817-9D0E34E4-A131-4D28-A916-E62642D91AC2

P2860

Q36142817-04A21244-6557-4D49-9391-AACE484EC366

Q36142817-10561789-A180-4B1B-AC14-142239A167EA

Q36142817-107E813C-62A1-4633-AF2A-B098339B9EB6

Q36142817-3486E7EC-2124-4DF6-B515-F7BF4301FFDA

Q36142817-3C3F46A7-58B0-4B9A-87A1-79D72CA5998B

Q36142817-3FA1F1D7-C8E8-4A82-A521-ABB73BC2ABAE

Q36142817-43151118-1CE5-42A9-BB9C-5F3A2003C4E6

Q36142817-4C4D83B9-F3A5-475F-BE9B-F8CF1FBD8252

Q36142817-53BE27E6-B2A5-4A33-8643-A973C6070889

Q36142817-73E313E1-BF27-453A-9AA8-4CDEE20068FE

P304

Q36142817-AF0059EB-27B6-4D2F-80AB-05116366C7F1

P31

Q36142817-FF68EF8D-6976-4593-A9E5-AF54984D4811

P356

Q36142817-DE4F1974-9263-4BC8-A1DF-0684012BCB71

P407

Q36142817-7759DA5A-DDD4-4600-8C06-8D69A70B4140

P433

Q36142817-AE6749B3-2E5E-4081-BA7E-27521A4E488A

P478

Q36142817-FD5437A7-E338-400C-ABA1-1089B51BB099

P577

Q36142817-A1B8B5C0-60E8-4CD4-AC2D-EB1AE8D56C77

P5875

Q36142817-37EF577A-8500-4B77-AB17-D68E7CFB64BF

P698

Q36142817-B13E42C3-61FD-4912-88D1-C78102F600F3

P921

Q36142817-7E2CA687-B679-471E-B14B-3C9F4ABF24A6

P932

Q36142817-BFC8B831-27F9-41C4-9904-D28524DE04D5

P356

JNNP.2006.092122

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

The effect of the apolipoprote ...... n probable Alzheimer's disease

@en

P2093

Bentham P

http://www.w3.org/2001/XMLSchema#string

Coates J

http://www.w3.org/2001/XMLSchema#string

Haque S

http://www.w3.org/2001/XMLSchema#string

Harris J

http://www.w3.org/2001/XMLSchema#string

Holder R

http://www.w3.org/2001/XMLSchema#string

Lendon CL

http://www.w3.org/2001/XMLSchema#string

Pritchard AL

http://www.w3.org/2001/XMLSchema#string

Pritchard CW

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease

Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease.

Factors associated with psychotic symptoms in Alzheimer's disease.

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.

Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E.

apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice.

Memory self-appraisal and depressive symptoms in people at genetic risk for Alzheimer's disease.

P304

123-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.2006.092122

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6814586

http://www.w3.org/2001/XMLSchema#string

P698

16980336

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2077651

http://www.w3.org/2001/XMLSchema#string